Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to ECOG performance status: A subanalysis from the SHARP trial

被引：0
作者：
Raoul, J.
Santoro, A.
Beaugrand, M.
Marrero, J. A.
Moscovici, M.
Shan, M.
Nadel, A.
Voliotis, D.
Bruix, J.
Llovet, J. M.
机构：
[1] Ctr Eugene Marquis, Rennes, France
[2] Ist Clin Humanitas, Rozzano, Italy
[3] Hop Jean Verdier, Bondy, France
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] Bayer Schering Pharma, Milan, Italy
[6] Bayer HealthCare Pharmaceut, West Haven, CT USA
[7] Bayer Schering Pharma, Wuppertal, Germany
[8] Barcelona Clin, Liver Canc Grp, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4587
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of nintedanib vs sorafenib in Asian patients with advanced hepatocellular carcinoma (HCC): A randomised Phase II trial
    Yen, C.
    Kim, T. Y.
    Feng, Y. H.
    Chao, Y.
    Lin, D. Y.
    Studeny, M.
    Hocke, J.
    Huang, D. C. L.
    Ryoo, B. Y.
    Cheng, A. L.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S612 - S612
  • [22] Randomized phase II trial comparing the efficacy and safety of nintedanib versus sorafenib in patients with advanced hepatocellular carcinoma (HCC)
    Palmer, Daniel H.
    Ma, Yuk Ting
    Peck-Radosavljevic, Markus
    Ross, Paul J.
    Graham, Janet Shirley
    Fartoux, Laetitia
    Deptala, Andrzej
    Wenz, Arne
    Hocke, Julia
    Loembe, Arsene-Bienvenu
    Meyer, Tim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [23] Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET
    S. Negrier
    E. Jäger
    C. Porta
    D. McDermott
    M. Moore
    J. Bellmunt
    S. Anderson
    F. Cihon
    J. Lewis
    B. Escudier
    R. Bukowski
    [J]. Medical Oncology, 2010, 27 : 899 - 906
  • [24] Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET
    Negrier, S.
    Jaeger, E.
    Porta, C.
    McDermott, D.
    Moore, M.
    Bellmunt, J.
    Anderson, S.
    Cihon, F.
    Lewis, J.
    Escudier, B.
    Bukowski, R.
    [J]. MEDICAL ONCOLOGY, 2010, 27 (03) : 899 - 906
  • [25] Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma
    Ogasawara, Sadahisa
    Kanai, Fumihiko
    Obi, Shuntaro
    Sato, Shinpei
    Yamaguchi, Taketo
    Azemoto, Ryosaku
    Mizumoto, Hideaki
    Koushima, Youhei
    Morimoto, Naoki
    Hirata, Nobuto
    Toriyabe, Takeshi
    Shinozaki, Yusuke
    Ooka, Yoshihiko
    Mikata, Rintaro
    Chiba, Tetsuhiro
    Okabe, Shinichiro
    Imazeki, Fumio
    Yoshikawa, Masaharu
    Yokosuka, Osamu
    [J]. HEPATOLOGY INTERNATIONAL, 2011, 5 (03) : 850 - 856
  • [26] Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma
    Sadahisa Ogasawara
    Fumihiko Kanai
    Shuntaro Obi
    Shinpei Sato
    Taketo Yamaguchi
    Ryosaku Azemoto
    Hideaki Mizumoto
    Youhei Koushima
    Naoki Morimoto
    Nobuto Hirata
    Takeshi Toriyabe
    Yusuke Shinozaki
    Yoshihiko Ooka
    Rintaro Mikata
    Tetsuhiro Chiba
    Shinichiro Okabe
    Fumio Imazeki
    Masaharu Yoshikawa
    Osamu Yokosuka
    [J]. Hepatology International, 2011, 5 : 850 - 856
  • [27] Efficacy and tolerability of sorafenib in elderly patients with advanced hepatocellular carcinoma
    Wong, H.
    Yau, C. C.
    Yao, T.
    Tang, V.
    Chan, P.
    Chiu, J.
    Fan, S.
    Peon, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [28] Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis
    Federico, Alessandro
    Orditura, Michele
    Cotticelli, Gaetano
    De Sio, Ilario
    Romano, Marco
    Gravina, Antonietta Gerarda
    Dallio, Marcello
    Fabozzi, Alessio
    Ciardiello, Fortunato
    Loguercio, Carmela
    De Vita, Ferdinando
    [J]. ONCOLOGY LETTERS, 2015, 9 (04) : 1628 - 1632
  • [29] Safety and Efficacy of Sorafenib in Patients With Advanced Hepatocellular Carcinoma in Consideration of Concomitant Stage of Liver Cirrhosis
    Woerns, Marcus Alexander
    Weinmann, Arndt
    Pfingst, Kerstin
    Schulte-Sasse, Carla
    Messow, Claudia-Martina
    Schulze-Bergkamen, Henning
    Teufel, Andreas
    Schuchmann, Marcus
    Kanzler, Stephan
    Dueber, Christoph
    Otto, Gerd
    Galle, Peter Robert
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2009, 43 (05) : 489 - 495
  • [30] Efficacy and safety of nivolumab in asian patients with advanced hepatocellular carcinoma (HCC): Subanalysis of the CheckMate 040 Study
    Choo, S. P.
    Yau, T.
    Hsu, C.
    Kang, Y-K.
    Hou, M-M.
    Yeo, W.
    Numata, K.
    Chopra, A.
    Baakili, A.
    Dela Cruz, C.
    Zhao, H.
    Kudo, M.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
12345